Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 70858 CHARLOTTE, NC
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,630,126
+$8,915,808 QoQ
Shares Held
787,949
+22.8% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 192 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. SLS ranks #109 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in SLS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,630,126 787,949
2026-03-31 $2,714,318 641,683
2025-12-31 $380,524 100,935
2025-09-30 $67,860 42,150
2025-06-30 $75,727 34,579
2025-03-31 $671 622
2024-12-31 $594 572
2024-09-30 $657 526
2024-06-30 $686 577
2023-12-31 $44 42
2022-12-31 $112 48
2022-06-30 $54,117 24,268
2022-03-31 $144,661 21,656
2021-12-31 $175,853 31,800
2021-09-30 $402,041 43,891
2021-03-31 $3,416 400
2020-12-31 $2,324 400
2020-03-31 $2,050 1,185